Diabetes

n-3 PUFA may reduce markers of kidney disease in T2DM

(HealthDay)—In patients with type 2 diabetes and evidence of kidney injury, supplementation with n-3 long-chain polyunsaturated fatty acids (PUFA) does not reduce urine albumin excretion but is associated with a reduction ...

Diabetes

Sclerostin linked to vascular disease in type 2 diabetes

(HealthDay)—Circulating levels of the Wnt/β-catenin signaling inhibitor sclerostin are higher in patients with type 2 diabetes who also have atherosclerotic disease, according to a study published online Jan. 3 in Diabetes ...

Medications

FDA: Samsca may cause irreversible liver damage

(HealthDay)—Patients who take Samsca (tolvaptan) may be at elevated risk for significant liver injury, according to a Jan. 25 safety alert issued by the U.S. Food and Drug Administration.

Cardiology

Low ratio of n3:n6 fatty acids correlates with CAD progression

(HealthDay)—For statin-treated patients with coronary artery disease, decreases in the ratio of serum n-3 to n-6 polyunsaturated fatty acids (PUFAs) correlate with atherosclerosis progression, according to research published ...

Diabetes

Fetuin-A levels linked to cardiovascular disease risk

(HealthDay)—In elderly individuals without type 2 diabetes, high levels of fetuin-A, a protein that inhibits arterial calcification and insulin action, is associated with a lower risk of cardiovascular disease, according ...

Diabetes

Dietary PA/OA fat ratio may affect T2DM risk in women only

(HealthDay)—A diet low in palmitic acid (PA) and high in oleic acid (OA) improves insulin sensitivity and is associated with lower levels of markers of metabolic and oxidative stress in women only, according to a study ...

page 31 from 40